An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with numerous of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.
Several experts said the popularity for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or prison.
Service Response and Content Elimination
Based on the social media company, the platform has removed violative material and banned related keywords and query recommendations. The company stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.
Online Trading Operations
Research also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for preparing or administering at home.
After moments of entering one community, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Product Details and Pricing
Within these groups, posts display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has already seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject users to possibly significant health risks”.
